Latest Manufacturing News

Audinate delivered 1H25 results above guidance despite a transitional year marked by inventory adjustments, with software revenue growth and strategic product launches setting the stage for a return to growth in FY26.

Audinate Group Limited's half-year results reveal a sharp 38.4% revenue decline and a $2.2 million net loss, driven by reduced chip demand as customers clear inventory. Yet, growth in OEM partnerships hints at potential recovery.

International Graphite's Springdale Project achieves over 99.95% purity in graphite purification tests coordinated by Marubeni, signaling strong potential for battery market supply.

BlueScope Steel reported steady revenue of $8.59 billion for the first half of FY2025, maintaining solid earnings despite challenging raw material costs and subdued housing demand. The company’s diversified operations and ongoing capital investments underpin its resilience amid market headwinds.

BlueScope Steel reported a resilient $309 million underlying EBIT for 1H FY2025 despite depressed steel spreads, announcing a 30 cents per share interim dividend and extending its buy-back program. The company is targeting a $500 million incremental EBIT uplift by 2030 through cost initiatives and strategic growth projects.

Bluescope Steel Limited has announced a fully franked interim dividend of AUD 0.30 per share, reflecting confidence in its financial position for the half-year ending December 2024.

The a2 Milk Company delivered solid first-half FY25 results with revenue up 10.1% and net profit rising 7.6%, driven by strong growth in China and the USA despite supply constraints and ANZ challenges. The company also declared its first-ever interim dividend and upgraded its full-year outlook.

The a2 Milk Company has reported robust first-half FY25 results, boosting full-year guidance and declaring its inaugural dividend, underscoring confidence in its growth trajectory.

The a2 Milk Company Limited has reported solid revenue and profit growth for the half-year ending December 2024, alongside a confident dividend declaration reflecting its strengthened financial position.

Ecofibre Limited has restructured its Australian loan facilities, extending repayment terms and adjusting interest rates to support a more sustainable financial footing.

Imugene’s Phase 1b trial of azer-cel, an off-the-shelf CD19 CAR T therapy, reports a 57% complete response rate in heavily pretreated diffuse large B-cell lymphoma patients, signaling a promising new option in a challenging cancer landscape.

Civmec’s 1H FY25 results reveal robust revenue growth and a strong balance sheet, underpinned by a diversified project pipeline and strategic moves into naval shipbuilding and material handling equipment manufacturing.